Status:
COMPLETED
Individualization of Ovarian Stimulation Using AMH Maximizes the Benefits and Minimizes Complications and Risks
Lead Sponsor:
ANDROFERT - Clinica de Andrologia e Reproducao Humana
Conditions:
Infertility
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose oh the study is to determine the usefulness of anti-Mullerian hormone (AMH) to identify women at risk of excessive and poor response in controlled ovarian stimulation (COS) for in vitro fe...
Detailed Description
A group of 130 women undergoing conventional COS after pituitary down-regulation for IVF will be studied to determine the best cut-off points of AMH, using receiver operating characteristic (ROC) anal...
Eligibility Criteria
Inclusion
- women with in vitro fertilization treatment indication
Exclusion
- none
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT01887652
Start Date
March 1 2012
End Date
July 1 2013
Last Update
June 26 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Androfert
Campinas, São Paulo, Brazil, 13075-460